(Q46813161)

25 December 2017

title

Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy (English)

1 reference

25 December 2017

author name string

Ulrika Kjellström

1

1 reference

25 December 2017

Monica Lövestam-Adrian

2

1 reference

25 December 2017

Sten Andréasson

3

1 reference

25 December 2017

Vesna Ponjavic

4

1 reference

25 December 2017

publication date

10 January 2008

1 reference

25 December 2017

Documenta Ophthalmologica

published in

1 reference

25 December 2017

volume

117

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

93-101

1 reference

25 December 2017

Severe persistent visual field constriction associated with vigabatrin

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

Second study supports results of Whitehall study after retirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

No reversion in vigabatrin-associated visual field defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

Effects of vigabatrin on evoked potentials in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

Peripheral retinal dysfunction in patients taking vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-007-9108-3

No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group

21 January 2018

1 reference

12 December 2020

The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms

1 reference

12 December 2020

Visual field constriction and electrophysiological changes associated with vigabatrin.

1 reference

12 December 2020

Visual field and electrophysiological abnormalities due to vigabatrin

1 reference

12 December 2020

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

1 reference

12 December 2020

Characteristics of a unique visual field defect attributed to vigabatrin

1 reference

12 December 2020

Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.

1 reference

12 December 2020

Vigabatrin effect on inner retinal function

1 reference

12 December 2020

The legacy of vigabatrin in a regional epilepsy clinic

1 reference

12 December 2020

Visual field defects associated with vigabatrin therapy

1 reference

12 December 2020

Standard for clinical electroretinography (2004 update).

1 reference

12 December 2020

A controlled study comparing visual function in patients treated with vigabatrin and tiagabine

1 reference

12 December 2020

Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal

1 reference

12 December 2020

Reversibility of vigabratin-induced visual-field defect

1 reference

12 December 2020

Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina

1 reference

12 December 2020

Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin

1 reference

12 December 2020

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

12 December 2020

Vigabatrin toxicity in children

1 reference

12 December 2020

Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats

1 reference

12 December 2020

Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children

1 reference

12 December 2020

Is visual field constriction in epilepsy patients treated with vigabatrin reversible?

1 reference

12 December 2020

Recovery of visual field constriction following discontinuation of vigabatrin

1 reference

12 December 2020

Evoked potential monitoring of vigabatrin patients

1 reference

12 December 2020

Changes in the electroretinogram resulting from discontinuation of vigabatrin in children

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies

1 reference

12 December 2020

Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal

1 reference

12 December 2020

Characterization of vigabatrin‐associated optic atrophy

1 reference

12 December 2020

Vigabatrin: longterm follow-up of electrophysiology and visual field examinations

1 reference

12 December 2020

Visual function loss from vigabatrin: effect of stopping the drug

1 reference

12 December 2020

Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist.

1 reference

12 December 2020

Electro-ophthalmological recovery after withdrawal from vigabatrin

1 reference

12 December 2020

10.1007/S10633-007-9108-3

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017